Metric Finance
LearnFAQ
LearnFAQ

Learn / AURA

NASDAQ: AURA

Aura Biosciences (AURA) stock, explained like you're 5

Aura Biosciences trades on the Nasdaq under the ticker AURA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 678 million dollars.

Ticker
AURA
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 678 million dollars

Is Aura Biosciences a small, medium or large cap company?

No. Aura Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 678 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Aura Biosciences makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves AURA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Aura Minerals (NasdaqGS:AUGO) Shares Just Moved, So What Is Going On? (Simply Wall Street)
  • AURA MINERALS INC (NASDAQ:AUGO): A Decent Value Stock with Strong Growth and Undervalued Forward Earnings (ChartMill)
  • 55% of IT providers had a security incident involving personal devices in two years. Climb now offers Aura Business. (Stock Titan)
  • HNST,EXFY,VYGR,GLSI,UNFI,AURA,JOBY,NXH | Stock Prices | Quote Comparison Yahoo Finance (Yahoo! Finance Canada)
  • Aura Minerals Inc. AUGO Holds Gains As Momentum Builds (Timothy Sykes)

Follow AURA in your daily brief

Each trading day at 5 PM ET we post what happened to Aura Biosciences and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow AURA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Aura Biosciences stock

What does Aura Biosciences do?

Aura Biosciences trades on the Nasdaq under the ticker AURA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 678 million dollars.

What is the ticker symbol for Aura Biosciences?

Aura Biosciences trades under the ticker AURA on the Nasdaq.

What is Aura Biosciences's market cap?

Aura Biosciences is a small cap stock with a market cap of about 678 million dollars.

How does Aura Biosciences make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves AURA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow AURA stock every day?

Add AURA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow AURA daily

A free brief on Aura Biosciences and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare AURA: AURA vs ARGX, AURA vs RVMD, AURA vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed